-
Something wrong with this record ?
Cap analysis of gene expression reveals alternative promoter usage in a rat model of hypertension
S. Dahale, J. Ruiz-Orera, J. Silhavy, N. Hübner, S. van Heesch, M. Pravenec, SS. Atanur
Language English Country United States
Document type Journal Article
NLK
Directory of Open Access Journals
from 2018
Freely Accessible Science Journals
from 2018
PubMed Central
from 2018
ROAD: Directory of Open Access Scholarly Resources
from 2018
- MeSH
- Transcription, Genetic genetics MeSH
- Hypertension * genetics metabolism MeSH
- Rats MeSH
- Rats, Inbred SHR MeSH
- Promoter Regions, Genetic genetics MeSH
- Sequence Analysis, RNA methods MeSH
- Gene Expression Profiling methods MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
The role of alternative promoter usage in tissue-specific gene expression has been well established; however, its role in complex diseases is poorly understood. We performed cap analysis of gene expression (CAGE) sequencing from the left ventricle of a rat model of hypertension, the spontaneously hypertensive rat (SHR), and a normotensive strain, Brown Norway to understand the role of alternative promoter usage in complex disease. We identified 26,560 CAGE-defined transcription start sites in the rat left ventricle, including 1,970 novel cardiac transcription start sites. We identified 28 genes with alternative promoter usage between SHR and Brown Norway, which could lead to protein isoforms differing at the amino terminus between two strains and 475 promoter switching events altering the length of the 5' UTR. We found that the shift in Insr promoter usage was significantly associated with insulin levels and blood pressure within a panel of HXB/BXH recombinant inbred rat strains, suggesting that hyperinsulinemia due to insulin resistance might lead to hypertension in SHR. Our study provides a preliminary evidence of alternative promoter usage in complex diseases.
Charité Universitätsmedizin Berlin Germany
DZHK Partner Site Berlin Berlin Germany
Institute of Physiology of the Czech Academy of Sciences Prague Czech Republic
Princess Máxima Center for Pediatric Oncology Utrecht Netherlands
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22011372
- 003
- CZ-PrNML
- 005
- 20220506131457.0
- 007
- ta
- 008
- 220425s2022 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.26508/lsa.202101234 $2 doi
- 035 __
- $a (PubMed)34996843
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Dahale, Sonal $u Department of Metabolism, Digestion, and Reproduction, Faculty of Medicine, Imperial College London, London, UK $u Department of Microbial Sciences, Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK
- 245 10
- $a Cap analysis of gene expression reveals alternative promoter usage in a rat model of hypertension / $c S. Dahale, J. Ruiz-Orera, J. Silhavy, N. Hübner, S. van Heesch, M. Pravenec, SS. Atanur
- 520 9_
- $a The role of alternative promoter usage in tissue-specific gene expression has been well established; however, its role in complex diseases is poorly understood. We performed cap analysis of gene expression (CAGE) sequencing from the left ventricle of a rat model of hypertension, the spontaneously hypertensive rat (SHR), and a normotensive strain, Brown Norway to understand the role of alternative promoter usage in complex disease. We identified 26,560 CAGE-defined transcription start sites in the rat left ventricle, including 1,970 novel cardiac transcription start sites. We identified 28 genes with alternative promoter usage between SHR and Brown Norway, which could lead to protein isoforms differing at the amino terminus between two strains and 475 promoter switching events altering the length of the 5' UTR. We found that the shift in Insr promoter usage was significantly associated with insulin levels and blood pressure within a panel of HXB/BXH recombinant inbred rat strains, suggesting that hyperinsulinemia due to insulin resistance might lead to hypertension in SHR. Our study provides a preliminary evidence of alternative promoter usage in complex diseases.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a stanovení celkové genové exprese $x metody $7 D020869
- 650 12
- $a hypertenze $x genetika $x metabolismus $7 D006973
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a promotorové oblasti (genetika) $x genetika $7 D011401
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani inbrední SHR $7 D011918
- 650 _2
- $a sekvenční analýza RNA $x metody $7 D017423
- 650 _2
- $a genetická transkripce $x genetika $7 D014158
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Ruiz-Orera, Jorge $u Cardiovascular and Metabolic Sciences, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany
- 700 1_
- $a Silhavy, Jan $u Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Hübner, Norbert $u Cardiovascular and Metabolic Sciences, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany $u Charité -Universitätsmedizin, Berlin, Germany $u DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, Berlin, Germany
- 700 1_
- $a van Heesch, Sebastiaan $u Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands $1 https://orcid.org/0000000195931980
- 700 1_
- $a Pravenec, Michal $u Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Atanur, Santosh S $u Department of Metabolism, Digestion, and Reproduction, Faculty of Medicine, Imperial College London, London, UK santosh.atanur@imperial.ac.uk $u The National Institute for Health Research, Imperial Biomedical Research Centre, ITMAT Data Science Group, Imperial College London, London, UK $1 https://orcid.org/0000000236699787
- 773 0_
- $w MED00197314 $t Life science alliance $x 2575-1077 $g Roč. 5, č. 4 (2022)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34996843 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220425 $b ABA008
- 991 __
- $a 20220506131449 $b ABA008
- 999 __
- $a ok $b bmc $g 1789116 $s 1162570
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 5 $c 4 $e 20220107 $i 2575-1077 $m Life science alliance $n Life sci. alliance $x MED00197314
- LZP __
- $a Pubmed-20220425